News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
ALI HEALTH, Novartis Forge Digital Chronic Disease Partnership
ALI HEALTH (00241.HK) and Novartis announced a digital chronic disease partnership in the field of Chronic Spontaneous Urticaria (CSU).Both parties will focus on Novartis's glo...
Reset
Send
The window will close in 5 seconds
ALI HEALTH, Novartis Forge Digital Chronic Disease Partnership
Close
Recommend
17
Positive
31
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

ALI HEALTH (00241.HK)  -0.070 (-1.461%)    Short selling $109.33M; Ratio 72.778%   and Novartis announced a digital chronic disease partnership in the field of Chronic Spontaneous Urticaria (CSU).

Both parties will focus on Novartis's global first oral targeted urticaria drug, and leverage Alibaba Health's digital platform capabilities to provide integrated services ranging from disease education and medication guidance to full-cycle health management.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.